Development of anti-drug antibodies is associated with shortened survival in patients with metastatic melanoma treated with ipilimumab.
about
Development of anti-drug antibodies is associated with shortened survival in patients with metastatic melanoma treated with ipilimumab.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Development of anti-drug antib ...... anoma treated with ipilimumab.
@en
Development of anti-drug antib ...... anoma treated with ipilimumab.
@nl
type
label
Development of anti-drug antib ...... anoma treated with ipilimumab.
@en
Development of anti-drug antib ...... anoma treated with ipilimumab.
@nl
prefLabel
Development of anti-drug antib ...... anoma treated with ipilimumab.
@en
Development of anti-drug antib ...... anoma treated with ipilimumab.
@nl
P2093
P2860
P50
P1433
P1476
Development of anti-drug antib ...... lanoma treated with ipilimumab
@en
P2093
Anders H Kverneland
Christian Enevold
Claus H Nielsen
P2860
P304
P356
10.1080/2162402X.2018.1424674
P577
2018-02-01T00:00:00Z